ARTICLE
Auteur(s) : Lina Houssami1, Fadi
Haddad1, Hassan El Teraifi2, Thomas G.
Berger1
1 Division of Dermatology, Tawam Hospital, P.O. Box
15258, Al Ain, Abu Dhabi, United Arab Emirates, Thomas Georg
Berger,
<bergerts@web.de>
2 Department of Histopathology, Tawam Hospital, Al Ain,
Abu Dhabi, UAE
Treatment of cutaneous leishmaniasis in children is a difficult
task, since available options are often toxic or painful. Here we
report on two siblings with an exceptional clinical response to
topical treatment with 20% paromomycin, without scar formation. In
addition, we critically discuss the possibility of direct contact
transmission between these two children.
Cutaneous leishmaniasis (CL) is endemic in many countries in the
Middle East [1]. In the United Arab Emirates the epidemiological
situation is unclear, but cases are seen in patients returning from
neighbouring countries such as Saudi Arabia and Iran, where CL is a
major health problem [2] CL is usually acquired through the bite of
an infected sandfly. In addition, CL has been transmitted by
deliberate scarification [3] and through breast feeding [4]. Direct
transmission due to close contact (e.g. within families) is
otherwise almost unreported.
We report here on the exceptional response to topical paromomycin,
which was easy to use and well tolerated. In addition, due to the
latency of the skin eruption in the girl and the clinical
history – the girl kissed her brother frequently on the
face – the possibility of direct contact transmission was
considered.
Case reports
A 2-year-old boy presented with erythematous and crusted nodules
on his left cheek and right thigh of 5 months duration (figure 1A). The family
spent the summer in Saudi-Arabia, the parents reported multiple
insect bites.
Cytology: A smear from a facial lesion showed abundant leishmania
amastigotes (figure
1C), electron microscopic examination confirmed the
presence of leishmania parasites (figure 1C, insert).
The 7-year-old sister presented with an erythematous crusted
swelling on the upper lip, which appeared 4 months later than
in her brother (figure
1B). Insect bites were not remembered.
A smear revealed the same cytological appearance with multiple
leishmania parasites (figure 1D).
100 mg itraconazole daily was given orally for 6 weeks
to both children without improvement. Therefore, topical
paromomycin 20% in a 10% urea-containing formulation was applied
twice daily for 6 weeks, with excellent healing and no scar
formation (figure 1E and
F).
Cutaneous leishmaniasis (CL) expresses various clinical patterns
from self-healing sores to extensive lesions with severe
disfigurement. To date, there is no ideally safe, simple and
effective treatment, especially for small children. Systemic or
local chemotherapy with pentavalent antimonials is associated with
significant toxicity and requires multiple injections. Azole
derivatives are an alternative [5], but not always effective.
Likewise, many of the topical treatment options such as curettage,
cryotherapy, heat application or photodynamic therapy are painful
and therefore not feasible for young children. The topical
treatment with paromomycin 20% under occlusive dressing has been
proven effective in controlled studies [6]. It is a safe and
practically painless therapy. In our cases, topical paromomycin
over a total of 6 weeks resulted in excellent healing with no
scar formation.
The interesting question remains, did the girl acquire the disease
directly by frequently kissing her brother, which was reported by
the mother and witnessed by the treating physician? CL is usually
transmitted through the bite of an infected sandfly. Since
deliberate scarification as a form of active immunotherapy has been
reported for centuries, direct contact transmission is in principle
possible, however, it is rarely reported [3, 4]. In fact, we did
not find a single epidemiological study which has addressed whether
or not leishmaniasis can be transmitted by direct contact. This
problem is admittedly difficult to tackle, since most cases occur
in endemic areas and the incubation period has such a great
variability that even if direct transmission is considered
clinically, a vector borne transmission can hardly be ruled out. As
in our case, the skin around the lips often is macerated which
would facilitate the entry of the parasite. Also, the specific
location and long latency makes it conceivable that direct contact
other than an insect bite transmitted the parasites. Clearly, more
information is needed, but we see this correspondence as a starting
point to stimulate future studies in that direction. n
1. Hepburn NC. Cutaneous leishmaniasis. Clin Exp
Dermatol 2000; 25: 363-70.
2. Uthman MA, Satir, AA, Tabbara KS. Clinical and
histopathological features of zoonotic cutaneous Leishmaniasis in
Saudi Arabia. J Eur Acad Dermatol Venereol 2005; 19:
431-6.
3. Itani ZS, Moubayed AP, Huth F. Experimental
inoculation of Leishmaniasis tropical from man to man. Arch
Dermatol Res 1976; 256: 127-36.
4. Marsden PD, Almeida EA, Llanos-Cuentas EA, Costa
JL, Megalhaes AV, Peterson NE, Cuba CC, Barreto AC. Leishmania
braziliensis braziliensis infection of the nipple. Br Med J
1985; 290: 433-4.
5. Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M,
Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous
leishmaniasis caused by leishmania major. N Engl J Med 2002;
346: 891-5.
6. Shazad B, Abbaszadeh B, Khamesipour A. Comparison
of topical paromomycin sulfate (twice/day) with intralesional
meglumine antimonite for the treatment of cutaneous leishmaniasis
caused by L. major. Eur J Dermatol 2005; 15: 85-7.
|